(19)
(11)
EP 0 662 831 A1
(12)
(43)
Date of publication:
19.07.1995
Bulletin 1995/29
(21)
Application number:
93921210.0
(22)
Date of filing:
02.09.1993
(51)
International Patent Classification (IPC):
C07D
409/
06
( . )
A61K
31/
40
( . )
A61K
31/
405
( . )
A61P
25/
04
( . )
A61K
9/
48
( . )
A61K
31/
4045
( . )
A61K
47/
14
( . )
A61P
29/
00
( . )
(86)
International application number:
PCT/US1993/008063
(87)
International publication number:
WO 1994/007488
(
14.04.1994
Gazette 1994/09)
(84)
Designated Contracting States:
AT BE CH DE DK FR GB GR IE IT LI LU NL PT SE
(30)
Priority:
07.10.1992
US 19920957930
(71)
Applicant:
PFIZER INC.
New York, N.Y. 10017 (US)
(72)
Inventor:
AHMED, Imran
Gales Ferry, CT 06335 (US)
(74)
Representative:
Moore, James William, Dr., et al
Pfizer Limited Ramsgate Road
Sandwich Kent CT13 9NJ
Sandwich Kent CT13 9NJ (GB)
(54)
3-SUBSTITUTED 2-OXINDOLE-1-CARBOXAMIDE PHARMACEUTICAL COMPOSITIONS